Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study
Type: case control study
Author: Alberto Hern´andez a, Montserrat Vi˜nals b, Asunci´on Pablos b, Francisco Vil´as c, Peter J Papadakos d, Duminda N. Wijeysundera e, Sergio D. Bergese f, Marc Vives g,*
In this prospective case-control study of 18 patients with confirmed COVID-19 severe pneumonia, twice-daily ozonated autohemotherapy for 5 consecutive days was associated with a significant reduction in the time to clinical improvement. This case-control study provides novel new data pointing to the potential role of ozonated autohemotherapy for treatment of severe COVID-19 pneumonia.